Most Recent
It faced defeat at the Full Federal Court and encountered a deadlocked High Court, still Aristocrat persisted in its seven-year fight to get patent protection for the popular Lightning Link poker machine. The long game paid off.
Biotech Regeneron and drug company Bayer have wasted no time in challenging a decision that cleared the way for generic pharmaceutical manufacturer Sandoz to launch a version of top selling Eylea.
Intellectual property firm Wrays has lured a former special counsel at King & Wood Mallesons to join as the firm’s new head of trade marks.
Gaming giant Aristocrat has won its battle against a decision revoking four innovation patents covering its popular Lightning Links poker machine, in a major decision that clarifies the patentability of computer-implemented ideas.
An activist group has asked the High Court to overturn a decision finding it does not own the copyright for grim footage secretly obtained by trespassing at a Victorian slaughterhouse, arguing the case has consequences for press freedoms.
A judge has expressed frustration over the fourth discovery fight this year in Fortescue’s trade secrets case against Element Zero, as the green iron startup claims its bigger rival is trying to drag out the litigation.
A judge has ordered tech company Vehicle Management Systems to hurry up and choose between damages or an account of profits in its IP dispute with the city of Melbourne over a sensor-based system for timing parked vehicles.
Regeneron and Bayer have lost their bid to block generic drug maker Sandoz from launching a biosimilar of their blockbuster eye drug Eylea.
CBA-backed venture capital firm Wollemi has reached an agreement to resolve a trade mark dispute with the family office of Tesla chairwoman Robyn Denholm.
The High Court is poised to provide guidance on the defence of honest concurrent use in trade mark disputes, agreeing to hear an appeal by buy now, pay later giant Zip Co in its fight with Firstmac over the 'Zip' trade mark.